The American Hospital Association argues that the healthcare supply chain is not going to be back to “normal” anytime soon, despite estimates that still project its growth.
Pluvicto, a prostate cancer drug manufactured by Novartis, approved by the FDA in March 2022, has been in short supply for several months due to issues with delivery and manufacturing — but the shortage may be ending, according to NBC News.
Avanos Medical recalled 1,000 catheters April 21 with a Class I warning, the most serious type, because of cracked parts that can increase the risk of delayed or prevented ventilation. One death and four injuries have been reported.
Fresenius Kabi USA recalled 1,546 large infusion pumps in a Class I recall, the most serious type, because of a risk of leaking products entering the electrical system and shutting down the device.
WellSpan’s York (Pa.) Hospital has partnered to turn its plastic waste into concrete, which it will use on its next expansion, ABC affiliate WHTM reported April 19.
Less than half of health systems integrate clinicians into supply chain work, and this is barring hospitals from smoothening bumps in their supply chains, according to an April 13 post from McKinsey & Co.
The Federal Emergency Management Agency benchmarked $2.64 million for Danbury (Conn.) Hospital to reimburse supply costs incurred during the COVID-19 pandemic and “providing food delivery for hospital staff unable to leave the facility during self-quar…